HIF1A and neoplasm: This hypoxia-mediated increase in HIF-1α promotes tumor progression through the HIF-1α−dependent activation of multiple genes, whose expression enables cancer cells to survive, metastasize, and acquire resistance to antiangiogenic therapy6,7.